68Ga-DOTA-TATE PET/MR and PET/CT imaging ( DrugBank: DOTA-TATE )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 238 | Vitamin D-resistant rickets | 1 |
238. Vitamin D-resistant rickets
Clinical trials : 29 / Drugs : 25 - (DrugBank : 11) / Drug target genes : 4 - Drug target pathways : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04045834 (ClinicalTrials.gov) | May 5, 2019 | 4/8/2019 | Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia | Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia | PET / CT;PET / MR;Neuroendocrine Tumors;Osteomalacia | Device: 68Ga-DOTA-TATE PET/MR and PET/CT imaging | Wuhan Union Hospital, China | NULL | Recruiting | 20 Years | 80 Years | All | 60 | China |